NICPIME AM INJECTION 250 MG/1000 MG
By Nicpime AM
Rx
1 Injection in a Vial

Composition
Amikacin(250mg) + Cefepime(1000mg)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
October, 2025

liver
NICPIME AM INJECTION 250 MG/1000 MG is considered safe for individuals with liver disease based on the available data. There is no strong indication to adjust the dosage specifically for patients with liver issues. However, it is always advisable to consult your doctor before using this medication to ensure it is suitable for your individual condition.

kidney
NICPIME AM INJECTION 250 MG/1000 MG should be used carefully in individuals with kidney problems. Adjusting the dosage may be necessary. It is important to consult your doctor regarding the use of this medication.

alcohol
When taking NICPIME AM INJECTION 250 MG/1000 MG, caution is advised when consuming alcohol. It is recommended to consult your doctor before combining the two.

driving
NICPIME AM INJECTION 250 MG/1000 MG may cause decreased alertness, vision changes, sleepiness, and dizziness. It is advisable not to drive if experiencing these side effects.

pregnancy
NICPIME AM INJECTION 250 MG/1000 MG is not safe to use during pregnancy, as it can pose risks to the developing baby. Your doctor may only consider it in life-threatening situations if benefits outweigh risks. Always consult with your healthcare provider.

breastfeeding
NICPIME AM INJECTION 250 MG/1000 MG is considered safe for breastfeeding as studies show minimal transfer to breastmilk. However, prolonged use may lead to potential effects like rash and diarrhea.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹243
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024